HR 133
118th Congress
House
Health
Medical research
Medicare
Prescription drugs
MERIT Act
Everywhere this bill has been
13 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 19, 2024
Placed on the Union Calendar, Calendar No. 779.
Dec 19, 2024
Committee on Ways and Means discharged.
Dec 17, 2024
Referred to the Subcommittee on Health.
Nov 22, 2024
House Committee on Ways and Means Granted an extension for further consideration ending not later than Dec. 19, 2024.
Nov 22, 2024
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-764, Part I.
Dec 6, 2023
Ordered to be Reported (Amended) by the Yeas and Nays: 42 - 0.
Dec 6, 2023
Committee Consideration and Mark-up Session Held
Dec 5, 2023
Committee Consideration and Mark-up Session Held
Nov 15, 2023
Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by Voice Vote.
Nov 15, 2023
Subcommittee Consideration and Mark-up Session Held
Jan 20, 2023
Referred to the Subcommittee on Health.
Jan 9, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 9, 2023
Introduced in House
Plain-English summary
Mandating Exclusive Review of Individual Treatments (MERIT) Act
This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.
What's happening now
Placed on the Union Calendar, Calendar No. 779.